Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (13 quarters reported)
$173M in Q2 2013 → — now. Hover for any quarter.
As reported for the quarter ended June 30, 2016. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| NS No Securities To Report | NaN% | New | 0 | — |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended June 30, 2016 · filed July 19, 2016
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Abbvie Inc | Exited | −250,000 | −$14.3M | — |
| NS No Securities To Report | New | +0 | — | — |
quarter ended March 31, 2016 · filed May 05, 2016
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Oracle Corp | Exited | −500,000 | −$18.3M | — |
| Puma Biotechnology Inc | Exited | −220,780 | −$17.3M | — |
| Amgen Inc | Exited | −75,000 | −$12.2M | — |
| Abbvie Inc | Trimmed | −50,000 | −$2.86M | 100.0% |
| I Ignyta Inc | Exited | −46,721 | −$626K | — |
| ZA Zeltiq Aesthetics Inc | Exited | −16,119 | −$460K | — |
| I Immunomedics Inc | Exited | −100,000 | −$307K | — |
quarter ended December 31, 2015 · filed February 09, 2016
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Amgen Inc | Exited | −150,000 | −$20.7M | — |
| Oracle Corp | New | +500,000 | +$18.3M | 27.3% |
| Oracle Corp | Exited | −500,000 | −$18.1M | — |
| Abbvie Inc | New | +300,000 | +$17.8M | 26.6% |
| Ocular Therapeutix Inc | Exited | −1,233,285 | −$17.3M | — |
| Puma Biotechnology Inc | New | +220,780 | +$17.3M | 25.9% |
| AP Alexion Pharmaceuticals Inc | Exited | −100,000 | −$15.6M | — |
| Abbvie Inc | Exited | −250,000 | −$13.6M | — |
| GP Gw Pharmaceuticals PLC | Exited | −120,000 | −$11M | — |
| Biomarin Pharmaceutical Inc | Exited | −100,000 | −$10.5M | — |
Showing the 10 largest of 16 changes.
quarter ended September 30, 2015 · filed November 09, 2015
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Amgen Inc | New | +150,000 | +$20.7M | 15.5% |
| Oracle Corp | New | +500,000 | +$18.1M | 13.5% |
| AS Axovant Sciences Ltd | Exited | −692,961 | −$14.1M | — |
| Abbvie Inc | New | +250,000 | +$13.6M | 10.2% |
| GP Gw Pharmaceuticals PLC | New | +120,000 | +$11M | 8.2% |
| Biomarin Pharmaceutical Inc | New | +100,000 | +$10.5M | 7.9% |
| HP Hewlett Packard Co | Exited | −337,000 | −$10.1M | — |
| VM Violin Memory Inc | Exited | −3,934,580 | −$9.64M | — |
| CS Cypress Semiconductor Corp | New | +1,100,000 | +$9.37M | 7.0% |
| Ocular Therapeutix Inc | Added | +521,752 | +$7.34M | 13.0% |
Showing the 10 largest of 18 changes.
quarter ended June 30, 2015 · filed August 07, 2015
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| GP Gw Pharmaceuticals PLC | Exited | −171,496 | −$15.6M | — |
| AS Axovant Sciences Ltd | New | +692,961 | +$14.1M | 14.3% |
| Gilead Sciences Inc | Exited | −120,000 | −$11.8M | — |
| AP Alexion Pharmaceuticals Inc | New | +56,610 | +$10.2M | 10.4% |
| HP Hewlett Packard Co | New | +337,000 | +$10.1M | 10.3% |
| VM Violin Memory Inc | Added | +3,486,479 | +$8.54M | 9.8% |
| NS Nimble Storage Inc | Exited | −360,100 | −$8.03M | — |
| Amgen Inc | Added | +49,040 | +$7.53M | 15.1% |
| HO Hornbeck Offshore Svcs Inc N | New | +352,720 | +$7.24M | 7.4% |
| Ocular Therapeutix Inc | Added | +291,290 | +$6.13M | 15.2% |
Showing the 10 largest of 17 changes.
quarter ended March 31, 2015 · filed May 12, 2015
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| I Infoblox Inc | Trimmed | −1,065,984 | −$25.4M | 11.2% |
| KP Kite Pharma Inc | Trimmed | −261,650 | −$15.1M | 6.6% |
| Ocular Therapeutix Inc | Added | +345,863 | +$14.5M | 19.3% |
| Bluebird Bio Inc | Exited | −147,380 | −$13.5M | — |
| RS Rally Software Dev Corp | Exited | −1,163,626 | −$13.2M | — |
| OT Orexigen Therapeutics Inc | Exited | −1,891,000 | −$11.5M | — |
| Puma Biotechnology Inc | Exited | −55,005 | −$10.4M | — |
| Biomarin Pharmaceutical Inc | Exited | −91,840 | −$8.3M | — |
| NS Nimble Storage Inc | New | +360,100 | +$8.03M | 8.8% |
| Amgen Inc | New | +47,590 | +$7.61M | 8.3% |
Showing the 10 largest of 22 changes.
quarter ended December 31, 2014 · filed February 13, 2015
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| KP Kite Pharma Inc | New | +365,900 | +$21.1M | 13.8% |
| I Infoblox Inc | Added | +722,996 | +$14.6M | 19.8% |
| Bluebird Bio Inc | New | +147,380 | +$13.5M | 8.9% |
| Gilead Sciences Inc | New | +135,870 | +$12.8M | 8.4% |
| OT Orexigen Therapeutics Inc | New | +1,891,000 | +$11.5M | 7.5% |
| L Linkedin Corp | Exited | −51,070 | −$10.6M | — |
| Puma Biotechnology Inc | New | +55,005 | +$10.4M | 6.8% |
| Amgen Inc | Exited | −70,000 | −$9.83M | — |
| SP Sunesis Pharmaceuticals Inc | Exited | −1,320,000 | −$9.43M | — |
| KD King Digital Entmt PLC | Exited | −719,006 | −$9.13M | — |
Showing the 10 largest of 24 changes.
quarter ended September 30, 2014 · filed November 07, 2014
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Gilead Sciences Inc | Exited | −173,000 | −$14.3M | — |
| FN Fidelity Natl Information Sv | Exited | −255,910 | −$14M | — |
| V Vmware Inc | Exited | −122,300 | −$11.8M | — |
| L Linkedin Corp | New | +51,070 | +$10.6M | 11.8% |
| SC Salesforce Com Inc | New | +182,040 | +$10.5M | 11.6% |
| Amgen Inc | New | +70,000 | +$9.83M | 10.9% |
| RH Red Hat Inc | Exited | −175,480 | −$9.7M | — |
| SP Sunesis Pharmaceuticals Inc | New | +1,320,000 | +$9.43M | 10.5% |
| D Digitalglobe Inc | Exited | −299,650 | −$8.33M | — |
| A Aol Inc | Exited | −190,700 | −$7.59M | — |
Showing the 10 largest of 27 changes.
Loading...
